Johnson & Johnson wins U.S. FDA approval for bladder cancer drug

Johnson & Johnson's drug Balversa won U.S. approval as the first targeted therapy for advanced bladder cancer, the Food and Drug Administration announced on Friday.

from Reuters: Health https://reut.rs/2IwTFtN
via IFTTT

• Tweet
• Share
• Share
• Share
• Share